Beth Fand Incollingo

February 15, 2021

One patient with breast implant-associated anaplastic large cell lymphoma spoke out for herself throughout therapy — and encourages other patients do the same.

November 16, 2020

A retrospective study of patients with COVID-19 showed that those with cancer were not more likely to experience severe symptoms or death due to the virus than those without cancer. Rather, only age and obesity were associated with poor COVID-19 outcomes.

November 12, 2020

Paying attention to the updated nutritional labels on food can help Americans stay within dietary guidelines and prevent illness, including cancer.

November 11, 2020

One man discovered that his experience with testicular cancer inspired jokes he could share with others.

November 05, 2020

The FDA is reviewing what could become the first-ever medication specifically for kidney cancer associated with von Hippel-Lindau disease.

November 05, 2020

Three targeted drugs have recently been approved to treat diffuse large B-cell lymphoma, broadening the treatment options for patients with this aggressive blood cancer, according to Dr. Germame Ajebo.

November 04, 2020

The RACE for Children Act will create more clinical trial options for young patients with cancer and, ultimately, more pediatric oncology drugs.

November 04, 2020

One recently approved drug and two experimental treatments offer the promise of a wider range of options for patients with follicular lymphoma, according to Dr. Germame Ajebo.

October 30, 2020

Twelve works will be selected to appear in a 2021 CURE® calendar, and all submissions will be displayed in the magazine’s online art gallery.

October 29, 2020

Giving fewer courses of chemotherapy and no radiation could become a new standard for patients with stage 1 or 2 diffuse large B cell lymphoma based on the results of a recent study.

October 27, 2020

A meta-analysis of six clinical trials showed that standard treatment regimens for high-risk multiple myeloma may be more effective at delaying disease progression if they are given in combination with the targeted drug Darzalex (daratumumab).

October 23, 2020

Stephanie Walker, who was diagnosed with metastatic breast cancer in 2015, recalls how her disease has pulled the rug out from underneath her.

October 22, 2020

Susan Swanson, who was diagnosed with metastatic breast cancer in 2014, says it’s very important for patients to surround themselves with a good support network.

October 22, 2020

Kirby Lewis, who was diagnosed with breast cancer in 2012 and whose disease metastasized in 2016, says his diagnosis helped his care team detect a heart condition.

October 21, 2020

“The future is not yours,” says Pam Haldeman, who has metastatic breast cancer. “A way to get back a little bit of control is to be your own advocate and get aggressive in researching and going to every conference or retreat available.”

October 21, 2020

“Most kinds of breast cancer are potentially curable, but metastatic breast cancer is not,” says Kathleen Friel, lab director at the Burke Neurological Institute of Weill Cornell Medicine. “People assume, ‘Oh, you must be fine because you look fine.’ It puts a lot of expectations on us that, if somehow we’re strong enough, then we’ll beat this disease.”

October 20, 2020

A group extends a hand to those affected by breast or reproductive cancers, especially younger previvors, patients and caregivers.

October 17, 2020

Just one week of radiation therapy after surgery for early-stage breast cancer is as safe and effective as longer courses, researchers report.

October 13, 2020

Combining the immunotherapy Keytruda with a CAR-T cell therapy that targets the proteins CD19 and CD22 generates complete responses with minimal side effects, results from an early study demonstrate.

October 08, 2020

Adding the targeted drug Tukysa (tucatinib) to Herceptin (trastuzumab) and the chemotherapy Xeloda (capecitabine) lengthens life and time until disease progression in patients, without decreasing their health-related quality of life, researchers found in a follow-up to the HER2CLIMB study.

October 06, 2020

In a clinical trial, adding the CDK4/6 inhibitor Ibrance (palbociclib) to the hormonal treatment Faslodex (fulvestrant) delayed disease progression in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer.

October 02, 2020

After a recommendation against routine prostate cancer screening, rates of early disease declined while the incidence of advanced disease rose. The trend highlights the difficult balance between screening and potential overtreatment.

October 02, 2020

New treatments are needed for penile cancer, but it’s difficult to test drugs in clinical trials because the disease is so uncommon.

October 01, 2020

For some patients with metastatic kidney cancer, undergoing surgery after targeted or immune therapy sparks better health outcomes.

September 29, 2020

A growing number of treatments are available to men whose prostate cancer has spread and become resistant to hormonal therapy.

September 29, 2020

Five-year follow-up data from the phase 3 SOLO-1 trial demonstrates a nearly five-year delay in disease progression with Lynparza compared with a delay of just over a year with placebo in women with newly diagnosed, advanced ovarian cancer harboring a BRCA gene mutation.

September 29, 2020

New guidance from the Food and Drug Administration recommends that the makers of breast implants include a black-box warning, a patient decision checklist and other information on product labels that will help protect them against a cancer and an autoimmune condition that can arise from use of the devices.

September 29, 2020

A woman shares her late husband’s journey with advanced penile cancer to help others receive a diagnosis early, when the disease is still highly treatable and even curable.

September 28, 2020

After enjoying visits from therapy dogs during treatment for testicular cancer, a student pilot decides to volunteer to transport pets needing rescue, shelter or adoption.

September 28, 2020

Forward Momentum, a coalition launched by a biopharmaceutical company and three partners, focuses on the health disparities faced by Black men with prostate cancer.